{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:22:17Z","timestamp":1783948937715,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Medical College of Wisconsin: Department of Orthopaedic Surgery","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00198-020-05795-1","type":"journal-article","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T22:02:44Z","timestamp":1614722564000},"page":"1895-1898","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation"],"prefix":"10.1007","volume":"32","author":[{"given":"J. C.","family":"Horng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Van Eperen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. N.","family":"Wooldridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,2]]},"reference":[{"issue":"3","key":"5795_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4322\/acr.2017.031","volume":"7","author":"A Ghorbani-Aghbolaghi","year":"2017","unstructured":"Ghorbani-Aghbolaghi A, Darrow MA, Wang T (2017) Phosphaturic mesenchymal tumor (PMT): exceptionally rare disease, yet crucial not to miss. Autopsy Case Rep 7(3):32\u201337. https:\/\/doi.org\/10.4322\/acr.2017.031","journal-title":"Autopsy Case Rep"},{"key":"5795_CR2","first-page":"33","volume":"16","author":"RA McCance","year":"1947","unstructured":"McCance RA (1947) Osteomalacia with Looser\u2019s nodes (Milkman\u2019s syndrome) due to raised resistance to vitamin D acquired about the age of 15 years. Q J Med 16:33\u201346","journal-title":"Q J Med"},{"key":"5795_CR3","first-page":"554","volume":"14","author":"A Prader","year":"1959","unstructured":"Prader A, Illig J, Uehlinger E, Stalder G (1959) Rickets following bone tumor. Helv Paediatr Acta 14:554\u2013565","journal-title":"Helv Paediatr Acta"},{"issue":"4\u20135","key":"5795_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3109\/01913129109016242","volume":"15","author":"N Weidner","year":"1991","unstructured":"Weidner N (1991) Review and update: oncogenic osteomalacia-rickets. Ultrastruct Pathol 15(4\u20135):317\u2013333. https:\/\/doi.org\/10.3109\/01913129109016242","journal-title":"Ultrastruct Pathol"},{"issue":"10","key":"5795_CR5","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s40618-018-0849-5","volume":"41","author":"JM Boland","year":"2018","unstructured":"Boland JM, Tebben PJ, Folpe AL (2018) Phosphaturic mesenchymal tumors: what an endocrinologist should know. J Endocrinol Investig 41(10):1173\u20131184. https:\/\/doi.org\/10.1007\/s40618-018-0849-5","journal-title":"J Endocrinol Investig"},{"key":"5795_CR6","first-page":"331","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","author":"MK Drezner","year":"2004","unstructured":"Drezner MK (2004) Tumor-induced osteomalacia. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 4th edn. Lippincott Williams, Wilkins, Philadelphia, pp 331\u2013337","edition":"4"},{"key":"5795_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1210\/en.2010-0800","volume":"152","author":"M Hori","year":"2011","unstructured":"Hori M, Shimizu Y, Fukumoto S (2011) Minireview: fibroblast growth factor 23 in phosphate homeostasis and bone metabolism. Endocrinology. 152:4\u201310","journal-title":"Endocrinology."},{"issue":"4","key":"5795_CR8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMc070347","volume":"357","author":"E Hesse","year":"2007","unstructured":"Hesse E, Rosenthal H, Bastian L (2007) Radiofrequency ablation of a tumor causing oncogenic osteomalacia. N Engl J Med 357(4):422\u2013424","journal-title":"N Engl J Med"},{"key":"5795_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/9780470623992.ch69","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","author":"MD Ruppe","year":"2008","unstructured":"Ruppe MD, Jan de Beur SM (2008) Disorders of phosphate homeostasis. In: Rosen CJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 7th edn. American Society of Bone and Mineral Research, Washington DC, pp 317\u2013325","edition":"7"},{"issue":"10","key":"5795_CR10","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1210\/jc.2016-2052","volume":"101","author":"D El-Maouche","year":"2016","unstructured":"El-Maouche D, Sadowski SM, Papadakis GZ, Guthrie L, Cottle-Delisle C, Merkel R, Millo C, Chen CC, Kebebew E, Collins MT (2016) 68Ga-DOTATATE for tumor localization in tumor-induced osteomalacia. J Clin Endocrinol Metab 101(10):3575\u20133581. https:\/\/doi.org\/10.1210\/jc.2016-2052","journal-title":"J Clin Endocrinol Metab"},{"key":"5795_CR11","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/jbmr.316","volume":"26","author":"P Andreopoulou","year":"2011","unstructured":"Andreopoulou P, Dumitrescu CE, Kelly MH, Brillante BA, Cutler Peck CM, Wodajo FM, Chang R, Collins MT (2011) Selective venous sampling for the localization of phosphaturic mesenchymal tumors. J Bone Miner Res 26:1295\u20131302","journal-title":"J Bone Miner Res"},{"issue":"9","key":"5795_CR12","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1210\/jc.2013-4515","volume":"99","author":"S Jahdav","year":"2014","unstructured":"Jahdav S, Kasaliwal R, Shetty NS, Kulkarni S et al (2014) Radiofrequency ablation, an effective modality of treatment in tumor-induced osteomalacia: a case series of three patients. J Clin Endocrinol Metab 99(9):3049\u20133054. https:\/\/doi.org\/10.1210\/jc.2013-4515","journal-title":"J Clin Endocrinol Metab"},{"key":"5795_CR13","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1210\/jc.2012-1719","volume":"97","author":"S Tutton","year":"2012","unstructured":"Tutton S, Olson E, King D, Shaker JL (2012) Successful treatment of tumor-induced osteomalacia with CT-guided percutaneous ethanol and cryoablation. J Clin Endocrinol Metab 97:3421\u20133425","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"5795_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jbspin.2015.09.011","volume":"83","author":"A Igney-Oertel","year":"2016","unstructured":"Igney-Oertel A, Artunc F, Henes J, Hoffmann R, Clasen S (2016) Osteomalacia by a mesenchymal-FGF23-producing tumour: successful treatment with radiofrequency ablation. A case report. Joint Bone Spine 83(5):603\u2013604. https:\/\/doi.org\/10.1016\/j.jbspin.2015.09.011","journal-title":"Joint Bone Spine"},{"issue":"11","key":"5795_CR15","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1002\/jbmr.3219","volume":"32","author":"SH Tella","year":"2017","unstructured":"Tella SH, Amalou H, Wood BJ, Chang R, Chen CC, Robinson C, Millwood M, Guthrie LC, Xu S, Levy E, Krishnasamy V, Gafni RI, Collins MT (2017) Multimodality image-guided cryoablation for inoperable tumor-induced osteomalacia. J Bone Miner Res 32(11):2248\u20132256","journal-title":"J Bone Miner Res"},{"issue":"7","key":"5795_CR16","doi-asserted-by":"publisher","first-page":"e10178","DOI":"10.1002\/jbm4.10178","volume":"3","author":"SK Mishra","year":"2019","unstructured":"Mishra SK, Kuchay MS, Sen IB, Garg A, Baijal SS, Mithal A (2019) Successful management of tumor-induced osteomalacia with radiofrequency ablation: a case series. JBMR Plus 3(7):e10178. https:\/\/doi.org\/10.1002\/jbm4.10178","journal-title":"JBMR Plus"},{"key":"5795_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","volume":"i","author":"RJ Walton","year":"1975","unstructured":"Walton RJ, Bijvoet OLM (1975) Nomogram for derivation of renal threshold phosphate concentration. Lancet i:309\u2013310","journal-title":"Lancet"},{"issue":"4","key":"5795_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3346\/jkms.1994.9.4.289","volume":"9","author":"YK Park","year":"1994","unstructured":"Park YK et al (1994) Oncogenic Osteomalacia: a Clinicopathologic Study of 17 Bone Lesions. J Korean Med Sci 9(4):289. https:\/\/doi.org\/10.3346\/jkms.1994.9.4.289","journal-title":"J Korean Med Sci"},{"key":"5795_CR19","doi-asserted-by":"publisher","unstructured":"Yavropoulou MP et al (2018) Distant lung metastases caused by a histologically benign phosphaturic mesenchymal tumor. Endocrinol Diabetes Metab Case Rep 2018. https:\/\/doi.org\/10.1530\/edm-18-0023","DOI":"10.1530\/edm-18-0023"},{"issue":"3","key":"5795_CR20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/jbmr.3903","volume":"35","author":"X Li","year":"2020","unstructured":"Li X, Jiang Y, Huo L, Wu H, Liu Y, Jin J, Yu W, Lv W, Zhou L, Xia Y, Wang O, Li M, Xing X, Chi Y, Jiajue R, Cui L, Meng X, Xia W (2020) Nonremission and recurrent tumor-induced osteomalacia: a retrospective study. J Bone Miner Res 35(3):469\u2013477. https:\/\/doi.org\/10.1002\/jbmr.3903","journal-title":"J Bone Miner Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05795-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-020-05795-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05795-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T06:06:39Z","timestamp":1629871599000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-020-05795-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,2]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["5795"],"URL":"https:\/\/doi.org\/10.1007\/s00198-020-05795-1","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,2]]},"assertion":[{"value":"19 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr Sean Tutton is a consultant for Galil Medical, consultant for Stryker, consultant for IZI Medical, and provides research support for Siemens. Dr Joseph Shaker receives authorship royalties from McGraw-Hill and is a consultant for Shire, Alexion, and Ultragenyx. Jonathan Horng, Erik Van Eperen, Reena Singh, and Adam Wooldridge declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"(Include appropriate approvals or waivers)","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"(Include appropriate statements)","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"(Include appropriate statements)","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}